Alloy Therapeutics

Alloy Therapeutics, founded in 2017 and headquartered in Lexington, Massachusetts, focuses on enhancing drug discovery by providing broad access to innovative platforms and services. Its flagship platform, Alloy-Gx, offers a suite of royalty-free immunocompetent transgenic mice, which facilitate advanced in vivo human antibody discovery. By promoting non-exclusive access to essential drug discovery tools, Alloy Therapeutics aims to streamline the antibody discovery process, enabling scientists to conduct their research with greater ease and efficiency.

Kent Bondensgaard

Senior Vice President - Antibody Discovery Services

Ross Leimberg

Venture Partner

6 past transactions

Vernal Biosciences

Venture Round in 2022
Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.

Tegmine Therapeutics

Corporate Round in 2022
Developer of an antibody-based therapeutics platform designed to make sustainable cancer and tumor therapies. The company's platform uses a mix of biology, mass spectrometry, and machine learning to focus on identifying proteins with tumor-specific modifications that drive disease progression and severity, enabling physicians to develop next-generation antibody drugs that are more specific to the tumor, sparing normal healthy tissues.

Mytide Therapeutics

Series A in 2022
Mytide is committed to providing peptides to serve a diverse array of applications. During their beta phase, they intend to work closely with partners to overcome challenges in synthesizing and purifying particular classes of peptides of interest, identify useful peptide modifications, and design and construct peptide libraries. We provide initial partners access to their cloud platform for immediate ordering, properties calculator, order tracking, and interactive data display with guaranteed purities of >90%, 3 mg quantities, and 5-day turnaround of peptides up to length 40 AA.

Wheeler Bio

Seed Round in 2022
Wheeler Bio is a biomanufacturing company focused on enhancing the translation of therapeutic innovations into clinical applications. The company offers a platform that bridges critical gaps between discovery and early development, allowing biopharma companies to access rapid and high-quality biomanufacturing services. With its Portable CMC platform, Wheeler Bio aims to provide clients with a reliable and efficient pathway to the clinic, facilitating comprehensive discovery-to-IND programs. This approach seeks to democratize access to biomanufacturing, ultimately accelerating the development of new therapeutics.

Wheeler Bio

Funding Round in 2021
Wheeler Bio is a biomanufacturing company focused on enhancing the translation of therapeutic innovations into clinical applications. The company offers a platform that bridges critical gaps between discovery and early development, allowing biopharma companies to access rapid and high-quality biomanufacturing services. With its Portable CMC platform, Wheeler Bio aims to provide clients with a reliable and efficient pathway to the clinic, facilitating comprehensive discovery-to-IND programs. This approach seeks to democratize access to biomanufacturing, ultimately accelerating the development of new therapeutics.

Vernal Biosciences

Seed Round in 2021
Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.